Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;14(9):1148-1158.
doi: 10.1016/j.jalz.2018.04.009. Epub 2018 Jun 28.

Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys

Affiliations

Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys

May A Beydoun et al. Alzheimers Dement. 2018 Sep.

Abstract

Introduction: Infectious agents were recently implicated in Alzheimer's disease (AD) and etiology of other dementias, notably Helicobacter pylori.

Methods: We tested associations of H. pylori seropositivity with incident all-cause and AD dementia and with AD-related mortality among US adults in a retrospective cohort study. Data from the National Health and Nutrition Surveys III, phase 1 (1988-1991) and 1999-2000 linked with Medicare and National Death Index registries, were used (baseline age ≥45 y, follow-up to 2013, Npooled = 5927).

Results: A positive association between H. pylori seropositivity and AD mortality was found in men (hazard ratioadj, pooled = 4.33, 95% confidence interval: 1.51-12.41, P = .006), which was replicated for incident AD and all-cause dementia, with hazard ratioadj, pooled = 1.45 (95% confidence interval: 1.03-2.04, P = .035) and hazard ratioadj, III = 1.44 (95% confidence interval: 1.05-1.98, P = .022), respectively. These associations were also positive among higher socioeconomic status groups.

Discussion: In sum, H. pylori seropositivity's direct association with AD mortality, all-cause dementia, and AD dementia was restricted to men and to higher socioeconomic status groups.

Keywords: Aging; Alzheimer's disease; Dementia; Helicobacter pylori; Mortality.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no conflict of interest exists.

Figures

Fig. 1.
Fig. 1.
Participant flowchart. Sample 4, mean ± SD of follow-up time (months): AD deaths: NHANES III, phase I: 174.0 ± 86.1 NHANES 1999–00: 120.0 ± 38.1. Incident AD: NHANES III, phase I: 170.3 ± 86.5 NHANES 1999–00: 117.4 ± 40.7. Incident all-cause dementia: NHANES III, phase I: 165.3 ± 87.6 NHANES 1999–00: 114.7 ± 43.6. Additional missing data (n = 41 observations for pooled analysis, n = 38 for NHANES III, phase I, and n = 3 for NHANES 1999–00) is found for each type of analysis, given that some sample weights were not valid and/or observations end before enter (i.e., prevalent cases of AD and all-cause dementia). Abbreviations: AD, Alzheimer’ disease; H. pylori, Helicobacter pylori; NHANES, National Health and Nutrition Examination Surveys; SD, standard deviation.
Fig. 2.
Fig. 2.
Hazard rate of Alzheimer’s disease mortality by H. pylori seropositivity status from fully adjusted Cox PH models among (A) Men, (B) Women: NHANES III, phase 1 and NHANES 1999–00 (pooled sample). Analysis time is expressed in months. Smoothed hazard functions are obtained from the fully adjusted model (model 3) among men and women. Abbreviations: H. pylori, Helicobacter pylori; Hp IgG, H. pylori negative; Hp IgG+, H. pylori positive; NHANES, National Health and Nutrition Examination Surveys; PH, proportional hazards; IgG, Immunoglobulin G.

Comment in

References

    1. Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res 2012;43:600–8. - PubMed
    1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112–7. - PMC - PubMed
    1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013;9:63–75.e2. - PubMed
    1. Lindeboom J, Weinstein H. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer’s disease, and vascular cognitive impairment. Eur J Pharmacol 2004;490:83–6. - PubMed
    1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297:353–6. - PubMed

Publication types

Substances